As a leading expert in biopharma and technological innovation, Ivan Kairatov has dedicated his career to the intersection of health and R&D. Today, we delve into a groundbreaking study where artificial intelligence analyzed WhatsApp voice messages to detect major depressive disorder, a condition
The fight against hereditary cancer has long been a reactive battle waged with scalpels and surveillance, but a landmark clinical trial now suggests a future where the body's own immune system can be trained to intercept the disease before it ever takes root. Recent findings for an investigational
The path from discovering a suspicious breast lump to receiving a definitive diagnosis is often fraught with anxiety, culminating in a biopsy that, for a vast majority of individuals, confirms the lesion is benign. In the United States alone, an astonishing 75% to 80% of all breast biopsies yield
We're joined today by Ivan Kairatov, a biopharma expert whose work at the intersection of technology and research is pushing the boundaries of what’s possible in patient care. We'll be exploring a groundbreaking AI-powered wearable that translates silent throat movements into fluent speech for
Artificial intelligence has made remarkable strides in recognizing human emotions from facial expressions and tone of voice, but a groundbreaking new framework is now aiming for a far more ambitious goal: computationally modeling how emotions are formed in the first place. Researchers in Japan have
The pharmaceutical industry is in the midst of a monumental technological pivot, committing billions of dollars to the promise of artificial intelligence agent platforms in a bid to revolutionize its long-standing operational models. Spearheaded by landmark collaborations like the global
